(Press-News.org) A new study shows that individuals with bipolar disorder who are exposed to significant trauma may be at greater risk for suicide death, suggesting that clinical diagnosis of or genetic predisposition to trauma-related conditions could be important factors to consider in suicide prevention.
Suicide is the 10th leading cause of death in the United States, accounting for over 40,000 deaths each year, and suicide death rates are 10 to 30 times higher for people with bipolar disorder than for the general population.
The research, spearheaded by Eric Monson, MD, PhD, and Hilary Coon, PhD, from the University of Utah, in collaboration with Virginia Willour, PhD, from the University of Iowa, set out to identify unique risk factors for suicide attempt and death within bipolar disorder.
"There are many factors that go into increased risk for suicide--genetics is one of them," says Willour, a professor of psychiatry in the UI Carver College of Medicine. "We want to understand what the risk factors are so we can move forward with better interventions and decrease the rates of suicide."
The team's findings were recently published in a research paper, titled "Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach," in the journal Translational Psychiatry.
Monson, first author on the study and a former graduate student of Willour's, says this research is a first meaningful assessment of risk factors that are specific not just to suicide attempt but to suicide death.
"Even though it does not provide a definitive answer, this work provides information that supports the idea that the risk factors for suicide attempt and suicide death may differ from one another," Monson says. "And ongoing research is going to be really critical to make sure we make the best use of valuable resources to prevent suicide."
Primary results of the study demonstrate that diagnosis of trauma-associated disorders, such as post-traumatic stress disorder (PTSD), are much more frequent in individuals with bipolar disorder who died from suicide than within all other groups--including suicide attempt.
The researchers' analysis also demonstrates a genetic predisposition to developing PTSD within individuals with bipolar disorder who died from suicide.
Additionally, the findings suggest that PTSD genetic risk factors derived from males were found more frequently in individuals with bipolar disorder who died from suicide, but genetic risk factors derived from females were associated with both suicide death and attempt.
Understanding how genetic variation contributes to suicide risk can help identify different strategies or potential medications to bring relief to patients at greatest risk of suicide.
"This is not a job to us--it's not even a career," says Willour, a senior author on the study and a member of the Iowa Neuroscience Institute. "This is a mission, to decrease suicide rates and do it in a way that brings relief to the patient as soon as possible."
Funded primarily by a grant from the American Foundation for Suicide Prevention, the study is the largest combined clinical and genetic effort to investigate risk factors for suicide death in bipolar disorder and uses the single largest sample of individuals who have died from suicide in the world.
"There have been decades of work that have gone into preparing this data," Monson says. "We would have no access to data of this caliber, of these numbers, if it weren't for the efforts of collaboration. There have been hundreds of investigators, and thousands of individuals who have donated their time, their DNA samples--all of these different things to make this possible."
It is critical to identify these potential risk factors because death from suicide is inherently preventable, and any tools to better predict those at greatest risk may aid in leveraging highly limited mental-health resources to reach those who need it most.
"Suicide is preventable--that doesn't get said enough," Monson says. "That's why screening is so important, and that's why all these steps of research that we take really matter. When you have something that is the worst possible outcome for an illness but is completely preventable--we have to do something about that."
INFORMATION:
Researchers have made significant advancements in correlating aberrations in specific brain circuits with neuropsychiatric conditions like depression. However, it remains difficult to prove that damage to these circuits causes the symptoms themselves and that targeting them with therapeutics could help patients. By integrating brain lesion datasets with data on how two treatments -- deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) -- influence neuropsychiatric disorders, researchers from Brigham and Women's Hospital and collaborators developed a new brain mapping approach that may help clarify the cause of a variety of neuropsychiatric conditions and identify promising stimulation sites to target therapeutically. Findings are published ...
As the world continues to warm, many arid regions that already have marginal conditions for agriculture will be increasingly under stress, potentially leading to severe food shortages. Now, researchers at MIT have come up with a promising process for protecting seeds from the stress of water shortage during their crucial germination phase, and even providing the plants with extra nutrition at the same time.
The process, undergoing continued tests in collaboration with researchers in Morocco, is simple and inexpensive, and could be widely deployed in arid regions, the researchers say. ...
As atmospheric concentrations of CO2 continue to rise, we are putting future generations at risk of having to deal with a massive carbon debt. IIASA researchers and international colleagues are calling for immediate action to establish responsibility for carbon debt by implementing carbon removal obligations, for example, during the upcoming revision of the EU Emissions Trading Scheme.
Over the last several decades, governments have collectively pledged to slow global warming through accords such as the Kyoto Protocol and the Paris Agreement. Despite the ratification of these agreements by a large number of countries, the atmospheric concentration of CO2 continues to rise. At the rate we are going, we are well on our way to using up the remaining quantity of CO2 emissions to limit temperature ...
Doha, Qatar, July 8, 2021: In March 2020, thousands of scientists around the world united to answer a pressing and complex question: which genetic factors influence the wide variation in COVID-19 severity? Why are some patients severely affected while others escape with mild or no symptoms at all?
A comprehensive summary of their findings to date, published in Nature - the world's leading multidisciplinary science journal - revealed 13 loci, or locations in the human genome, that are strongly associated with infection or severe COVID-19. The researchers also identified causal factors such ...
In March of 2020, thousands of scientists around the world united to answer a pressing and complex question: what genetic factors influence why some COVID-19 patients develop severe, life-threatening disease requiring hospitalization, while others escape with mild symptoms or none at all?
A comprehensive summary of their findings to date, published in Nature, reveals 13 loci, or locations in the human genome, that are strongly associated with infection or severe COVID-19. The researchers also identified causal factors such as smoking and high body mass index. These results come from one of the largest ...
What The Study Did: The SARS-CoV-2 BNT162b2 (Pfizer-BioNTech) vaccine appeared to be safe and achieve satisfactory serologic status in patients with cancer. While there was a lag in antibody production compared with the rate in the noncancer control group, seroconversion occurred in most patients after the second dose.
Authors: Irit Ben-Aharon, M.D., Ph.D., of the Rambam Health Care Campus in Haifa, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2021.2675)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please ...
Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. "We've solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab", says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the results of her study are published in Nature Medicine.
While some cancer patients experience incredible results from immunotherapy, many others do not benefit from this treatment, which puts patients' ...
What The Study Did: A decline in COVID-19 cases after the vaccination of health care workers in a region of California that experienced high rates of COVID-19 disease over the winter is reported in this single-center study.
Authors: Shruti K. Gohil, M.D., M.P.H., of the University of California, Irvine School of Medicine, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.15980)
Editor's Note: Please see the article for additional information, including other ...
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer's. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.
In addition, the experiments yielded seven drugs that may be useful for treating faulty proteins linked to Parkinson's ...
HOUSTON - Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. The study, published today in Nature Medicine, also identified a potential new strategy to treat toxicity - while maintaining response - to combined immune checkpoint blockade through either IL-1R inhibition or manipulation of the gut microbiota.
Dual immune checkpoint therapy has contributed to progress in overall survival for many cancer types, including ...
